Literature DB >> 3733357

Salvage of angioaccess after late thrombosis of radiocephalic fistulas for hemodialysis.

A Romero, J R Polo, E Garcia Morato, J L Garcia Sabrido, A Quintans, J P Ferreiroa.   

Abstract

A retrospective study of 44 surgical procedures performed in 39 patients with late occlusions of radiocephalic fistulas for hemodialysis is reported. In 6 cases (13.6%) no apparent anatomical cause was found, and a simple thrombectomy was performed as a corrective procedure. Some sort of arterial and/or venous stenosis was present in the other 38 cases. In 11 cases with evidence of mild localized vascular stenosis we performed a thrombectomy and then an endoluminal angioplasty with a balloon catheter and Bakes dilators. In 26 cases, with more severe degrees of stenosis, we made a proximal new fistula in the distal portion of the forearm, bypassing the vascular stenosis, either end-to-end radiocephalic or with interposition of a short segment of PTFE graft. The best results were achieved with the creation of a proximal new fistula, which resulted in almost 50% cumulative patency rates at 2 years, with no immediate failures. We think that an attempt at angioaccess salvage should be made in every case of late thrombosis of radiocephalic fistulas.

Entities:  

Mesh:

Year:  1986        PMID: 3733357

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  2 in total

Review 1.  Definitions and End Points for Interventional Studies for Arteriovenous Dialysis Access.

Authors:  Gerald A Beathard; Charmaine E Lok; Marc H Glickman; Ahmed A Al-Jaishi; Donna Bednarski; David L Cull; Jeffery H Lawson; Timmy C Lee; Vandana D Niyyar; Donna Syracuse; Scott O Trerotola; Prabir Roy-Chaudhury; Surendra Shenoy; Margo Underwood; Haimanot Wasse; Karen Woo; Theodore H Yuo; Thomas S Huber
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-20       Impact factor: 8.237

2.  Peripherally inserted central catheters and other intravascular devices: how safe are they for hemodialysis patients?

Authors:  Roman Shingarev; Michael Allon
Journal:  Am J Kidney Dis       Date:  2012-10       Impact factor: 8.860

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.